SBIR/STTR Research Award

MOTION AND SLEEP: NEUROPSYCHOLOGY AND BIOMARKERS

Award identifier 3c35a600f971c8189b12bbca889f732c39125360feade261cc9d48cfa7ec936bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,893

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
RSK ASSESSMENTS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Mobility or "self-motion" is fundamental for adaptation and survival in 3D visual and gravitational worlds where "optic flow" provides dominant information. Normal information from vestibular and kinesthetic systems must be integrated to provide a common neural framework for self-motion. Conflicting sensory-motor conditions may rearrange normal relations among visual, vestibular, and kinesthetic cues. In moving environments, susceptible subjects may experience motion sickness or illusory self-motion, with cognitive performance disturbances. Pineal melatonin modulates sleep-wake cycles, drowsiness, mood, and cognitive performance. Sleep may be altered by vestibular stimulation changes in space sickness through relationships with the sopite syndrome, sometimes the sole motion sickness manifestation. Pituitary ACTH and adrenal cortisol regulate level of arousal, stress, and motion sickness susceptibility. Changes in cognitive performance and neurohormones occur in self-motion and in motion sickness. The aims of this proposal are to: expose young male and female adults to an optic display in a rotating optokinetic nystagmus drum to produce circular vection (CV) and symptoms of the sopite syndrome (SSS), and to determine whether small doses [0 or 3 mg] of oral (sublingual) melatonin can affect levels of endogenous salivary melatonin and cortisol, or increase the incidence, latency, and severity of CV and SSS.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.